Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02175680
What this trial is testing

Treatment Substitution With PRO 140 Monotherapy in Adult Subjects With HIV-1 Infection

Who this might be right for
HIVHuman Immunodeficiency Virus
CytoDyn, Inc. 43
Testing effectiveness (Phase 2)Study completedNCT00052117
What this trial is testing

Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens

Who this might be right for
HIV Infections
Pfizer 300
Post-approval studies (Phase 4)Ended earlyNCT02322099
What this trial is testing

Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss

Who this might be right for
Bone Demineralization
University College Dublin 53
Not applicableStudy completedNCT00000923
What this trial is testing

Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 110
Post-approval studies (Phase 4)Study completedNCT00192595
What this trial is testing

Tenofovir in HIV/HBV Coinfection

Who this might be right for
HIV InfectionHepatitis B Coinfection
Kirby Institute 36
Testing effectiveness (Phase 2)Study completedNCT03639311
What this trial is testing

Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting (LA) Cabotegravir (CAB) Plus LA Rilpivirine (RPV), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)-Positive Participants From the LATTE Study

Who this might be right for
HIV Infections
ViiV Healthcare 97
Not applicableActive Not RecruitingNCT04032028
What this trial is testing

Same-Day Antiretroviral Therapy Initiation

Who this might be right for
HIV Infections
Thai Red Cross AIDS Research Centre 2,500
Post-approval studies (Phase 4)Study completedNCT01270802
What this trial is testing

Effects of Switching Efavirenz to Raltegravir on Vascular Function and Bone Markers in HIV-infected Patients

Who this might be right for
HIV
Indiana University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06640192
What this trial is testing

Administration of High Doses of Antiretroviral Drugs to Eliminate the Latent HIV-1 Reservoir

Who this might be right for
HIV-1-infection
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 24
Large-scale testing (Phase 3)Looking for participantsNCT07682961
What this trial is testing

Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

Who this might be right for
HIV Infections
Gilead Sciences 590
Testing effectiveness (Phase 2)Study completedNCT03954327
What this trial is testing

Combination Antiretroviral Therapy (cART) for PBC

Who this might be right for
Primary Biliary Cholangitis
University of Alberta 37
Not applicableStudy completedNCT00273780
What this trial is testing

Highly Active Antiretroviral Therapy (HAART) Adherence Interventions

Who this might be right for
HIV Infections
University of Washington 400
Testing effectiveness (Phase 2)UnknownNCT00299897
What this trial is testing

SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients

Who this might be right for
HIV InfectionsHuman Immunodeficiency Virus
Samaritan Pharmaceuticals, Inc 60
Not applicableUnknownNCT05140603
What this trial is testing

Ambispective Cohort Study to Evaluate the Efficacy, Safety, and Tolerance of an Antiretroviral Regimen With Doravirine

Who this might be right for
Hiv
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 150
Early research (Phase 1)Study completedNCT01479361
What this trial is testing

Antiretroviral Drug Interaction Study in Volunteers With HIV

Who this might be right for
HIVPCPToxoplasmosis
National Institutes of Health Clinical Center (CC) 36
Not applicableStudy completedNCT01048671
What this trial is testing

Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 482
Testing effectiveness (Phase 2)Study completedNCT00333684
What this trial is testing

Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid

Who this might be right for
Human Immunodeficiency VirusFacial Lipoatrophy
Canadian Immunodeficiency Research Collaborative 36
Not applicableStudy completedNCT00006444
What this trial is testing

The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women

Who this might be right for
HIV InfectionsPapilloma
National Institute of Allergy and Infectious Diseases (NIAID) 160
Not applicableStudy completedNCT00002398
What this trial is testing

Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations

Who this might be right for
HIV Infections
Gilead Sciences
Not applicableActive Not RecruitingNCT05454852
What this trial is testing

Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in Zambia

Who this might be right for
HIV
Boston University 771
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation